Euskara
|
Español
|
English
Sign in
Groups
Researchers
Results
JOSE ANTONIO
IRIBARREN LOYARTE
PROFESORADO AGREGADO
Sunnybrook Health Science Centre
Toronto, Canadá
You are in
Collaborations
Sunnybrook Health Science Centre
Publications in collaboration with researchers from Sunnybrook Health Science Centre (1)
2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
Accessibility
|
Legal information
|
Contact
|
Sitemap
|
Help
UPV/EHU